soul trial oral semaglutide cardiovascular outcomes results 2025 nejm

soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM The Role of Glucagon-Like Peptide-1

Name: soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM The Role of Glucagon-Like Peptide-1
Brand: actil.am
SKU: 22225328683
Price: 23.60 USD
Availability: InStock
Rating: 4.287100000000001 (16 reviews)

SKU: 22225328683

4.3

USD23.60 USD61.60

Pay in 4 interest-free payments of $5.90 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

Alterations in acylcarnitine metabolism in the retina and retinal pigment epithelium/choroid tissue, especially decreased concentrations of short-chain or medium-chain odd-numbered acylcarnitine, may play a key role in accelerating the development of choroidal neovascularization and age-related macular degeneration [316]